Showing 1 - 5 results of 5 for search 'Toru Okamoto', query time: 0.02s
Refine Results
-
1
Vasoprotective effects of lysophosphatidic acid inhibit vascular injury caused by SARS-CoV-2 infection by Fumitaka Muramatsu, Naoi Hosoe, Tatsuya Suzuki, Teppei Shimamura, Yumiko Hayashi, Kazuhiro Takara, Lamri Lynda, Anna Shimizu, Weizhen Jia, Yoshimi Noda, Nobuyuki Takakura, Toru Okamoto, Hiroyasu Kidoya
Published 2025-07-01Get full text
Article -
2
Engineered ACE2 decoy in dry powder form for inhalation: A novel therapy for SARS-CoV-2 variants by Takaaki Ito, Tatsuya Suzuki, Yusuke Sakai, Keisuke Nishioka, Yumi Itoh, Kentarou Sakamoto, Nariko Ikemura, Satoaki Matoba, Yasunari Kanda, Junichi Takagi, Toru Okamoto, Kohei Tahara, Atsushi Hoshino
Published 2025-06-01Get full text
Article -
3
Evolutionary dynamics of heparan sulfate utilization by SARS-CoV-2 by Shuhei Higuchi, Yafei Liu, Jun Shimizu, Chikako Ono, Yumi Itoh, Wataru Nakai, Hui Jin, Kazuki Kishida, Kazuo Takayama, Toru Okamoto, Yoshiko Murakami, Taroh Kinoshita, Yoshiharu Matsuura, Tatsuo Shioda, Hisashi Arase
Published 2025-08-01Get full text
Article -
4
Host-derived apolipoproteins play comparable roles with viral secretory proteins Erns and NS1 in the infectious particle formation of Flaviviridae. by Takasuke Fukuhara, Tomokazu Tamura, Chikako Ono, Mai Shiokawa, Hiroyuki Mori, Kentaro Uemura, Satomi Yamamoto, Takeshi Kurihara, Toru Okamoto, Ryosuke Suzuki, Kentaro Yoshii, Takeshi Kurosu, Manabu Igarashi, Hiroshi Aoki, Yoshihiro Sakoda, Yoshiharu Matsuura
Published 2017-06-01Get full text
Article -
5
In vivo production of engineered ACE2 decoy protects lungs from SARS-CoV-2 infection by Yuta Suzuki, Takayuki Miyazaki, Yoko Ida, Tatsuya Suzuki, Yumi Itoh, Shuto Nakao, Keita Kondo, Kenji Kubara, Keisuke Nishioka, Hiroki Muto, Ryuji Watari, Toshifumi Hirayama, Dai Kakiuchi, Shinya Sato, Satoshi Inoue, Yoshifumi Uemoto, Yohei Mukai, Atsushi Hoshino, Toru Okamoto, Junji Matsui
Published 2025-03-01Get full text
Article